171 related articles for article (PubMed ID: 7575639)
1. Inhibition of 2,3-oxidosqualene cyclase and sterol biosynthesis by 10- and 19-azasqualene derivatives.
Viola F; Brusa P; Balliano G; Ceruti M; Boutaud O; Schuber F; Cattel L
Biochem Pharmacol; 1995 Sep; 50(6):787-96. PubMed ID: 7575639
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of sterol biosynthesis in Saccharomyces cerevisiae and Candida albicans by 22,23-epoxy-2-aza-2,3-dihydrosqualene and the corresponding N-oxide.
Balliano G; Milla P; Ceruti M; Carrano L; Viola F; Brusa P; Cattel L
Antimicrob Agents Chemother; 1994 Sep; 38(9):1904-8. PubMed ID: 7810997
[TBL] [Abstract][Full Text] [Related]
3. 19-Azasqualene-2,3-epoxide and its N-oxide: metabolic fate and inhibitory effect on sterol biosynthesis in Saccharomyces cerevisiae.
Milla P; Viola F; Ceruti M; Rocco F; Cattel L; Balliano G
Lipids; 1999 Jul; 34(7):681-8. PubMed ID: 10478925
[TBL] [Abstract][Full Text] [Related]
4. Differential inhibition of fungal oxidosqualene cyclase by 6E and 6Z isomers of 2,3-epoxy-10-aza-10,11-dihydrosqualene.
Balliano G; Milla P; Ceruti M; Viola F; Carrano L; Cattel L
FEBS Lett; 1993 Apr; 320(3):203-6. PubMed ID: 8462686
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cholesterol biosynthesis in 3T3 fibroblasts by 2-aza-2,3-dihydrosqualene, a rationally designed 2,3-oxidosqualene cyclase inhibitor.
Gerst N; Schuber F; Viola F; Cattel L
Biochem Pharmacol; 1986 Dec; 35(23):4243-50. PubMed ID: 3790151
[TBL] [Abstract][Full Text] [Related]
6. 22,23-Epoxy-2-aza-2,3-dihydrosqualene derivatives: potent new inhibitors of squalene 2,3-oxide-lanosterol cyclase.
Viola F; Ceruti M; Balliano G; Caputo O; Cattel L
Farmaco; 1990 Sep; 45(9):965-78. PubMed ID: 2282128
[TBL] [Abstract][Full Text] [Related]
7. 2,3-Oxidosqualene cyclase: from azasqualenes to new site-directed inhibitors.
Cattel L; Ceruti M; Balliano G; Viola F; Grosa G; Rocco F; Brusa P
Lipids; 1995 Mar; 30(3):235-46. PubMed ID: 7791532
[TBL] [Abstract][Full Text] [Related]
8. 2,3-Epoxy-10-aza-10,11-dihydrosqualene, a high-energy intermediate analogue inhibitor of 2,3-oxidosqualene cyclase.
Ceruti M; Balliano G; Viola F; Grosa G; Rocco F; Cattel L
J Med Chem; 1992 Aug; 35(16):3050-8. PubMed ID: 1501233
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of sterol biosynthesis in Saccharomyces cerevisiae by N,N-diethylazasqualene and derivatives.
Balliano G; Viola F; Ceruti M; Cattel L
Biochim Biophys Acta; 1988 Mar; 959(1):9-19. PubMed ID: 3278744
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and inhibition studies of sulfur-substituted squalene oxide analogues as mechanism-based inhibitors of 2,3-oxidosqualene-lanosterol cyclase.
Stach D; Zheng YF; Perez AL; Oehlschlager AC; Abe I; Prestwich GD; Hartman PG
J Med Chem; 1997 Jan; 40(2):201-9. PubMed ID: 9003518
[TBL] [Abstract][Full Text] [Related]
11. Effects of a 2,3-oxidosqualene-lanosterol cyclase inhibitor 2,3:22,23-dioxidosqualene and 24,25-epoxycholesterol on the regulation of cholesterol biosynthesis in human hepatoma cell line HepG2.
Dollis D; Schuber F
Biochem Pharmacol; 1994 Jul; 48(1):49-57. PubMed ID: 8043030
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of fungal and mammalian sterol biosynthesis by 2-aza-2,3-dihydrosqualene.
Ryder NS; Dupont MC; Frank I
FEBS Lett; 1986 Aug; 204(2):239-42. PubMed ID: 3525224
[TBL] [Abstract][Full Text] [Related]
13. Rationally designed inhibitors as tools for comparing the mechanism of squalene-hopene cyclase with oxidosqualene cyclase.
Viola F; Ceruti M; Cattel L; Milla P; Poralla K; Balliano G
Lipids; 2000 Mar; 35(3):297-303. PubMed ID: 10783007
[TBL] [Abstract][Full Text] [Related]
14. Structural and stereoelectronic requirements for the inhibition of mammalian 2,3-oxidosqualene cyclase by substituted isoquinoline derivatives.
Barth MM; Binet JL; Thomas DM; de Fornel DC; Samreth S; Schuber FJ; Renaut PP
J Med Chem; 1996 Jun; 39(12):2302-12. PubMed ID: 8691425
[TBL] [Abstract][Full Text] [Related]
15. In vitro inhibition of animal and higher plants 2,3-oxidosqualene-sterol cyclases by 2-aza-2,3-dihydrosqualene and derivatives, and by other ammonium-containing molecules.
Duriatti A; Bouvier-Nave P; Benveniste P; Schuber F; Delprino L; Balliano G; Cattel L
Biochem Pharmacol; 1985 Aug; 34(15):2765-77. PubMed ID: 4015713
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cholesterol synthesis by cyclopropylamine derivatives of squalene in human hepatoblastoma cells in culture.
Van Sickle WA; Angelastro MR; Wilson P; Cooper JR; Marquart A; Flanagan MA
Lipids; 1992 Mar; 27(3):157-60. PubMed ID: 1326069
[TBL] [Abstract][Full Text] [Related]
17. Preferential cyclization of 2,3(S):22(S),23-dioxidosqualene by mammalian 2,3-oxidosqualene-lanosterol cyclase.
Boutaud O; Dolis D; Schuber F
Biochem Biophys Res Commun; 1992 Oct; 188(2):898-904. PubMed ID: 1445330
[TBL] [Abstract][Full Text] [Related]
18. Analogs of squalene and oxidosqualene inhibit oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae.
Oliaro-Bosso S; Ceruti M; Balliano G; Milla P; Rocco F; Viola F
Lipids; 2005 Dec; 40(12):1257-62. PubMed ID: 16477810
[TBL] [Abstract][Full Text] [Related]
19. Potent inhibition of cholesterol biosynthesis in 3T3 fibroblasts by N-[(1,5,9)-trimethyldecyl]-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol, a new 2,3-oxidosqualene cyclase inhibitor.
Gerst N; Duriatti A; Schuber F; Taton M; Benveniste P; Rahier A
Biochem Pharmacol; 1988 May; 37(10):1955-64. PubMed ID: 3377803
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of 2,3-oxidosqualene cyclases.
Taton M; Benveniste P; Rahier A; Johnson WS; Liu HT; Sudhakar AR
Biochemistry; 1992 Sep; 31(34):7892-8. PubMed ID: 1510977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
